What is Saxenda?
Saxenda® (liraglutide) is a prescription weight loss medication used for long-term weight management in adults with obesity, or those who are overweight with related health conditions.
It belongs to a class of medicines known as GLP-1 receptor agonists and is designed to help regulate appetite, reduce calorie intake, and support gradual, sustained weight loss when combined with diet and increased physical activity.
Unlike newer weekly treatments, Saxenda is administered as a once-daily injection, providing continuous appetite control throughout the day for those who are prescribed it.
How Saxenda works in the body
Saxenda contains liraglutide, a synthetic version of the natural hormone GLP-1 (glucagon-like peptide-1), which is released in response to food intake. GLP-1 helps regulate hunger, digestion, and energy balance.
Once administered, liraglutide binds to GLP-1 receptors in multiple areas, particularly the hypothalamus (appetite control), the gastrointestinal system, and the pancreas—supporting metabolic regulation as part of an overall care plan.
Core mechanisms explained
- Central appetite regulation (brain)Saxenda acts on the hypothalamus, reducing hunger signals and influencing food-related behaviour. Many people report less "food noise," better portion control, and lower overall calorie intake.
- Delayed gastric emptyingLiraglutide slows how quickly food leaves the stomach, prolonging fullness after meals, reducing snacking between meals, and supporting more stable appetite patterns.
- Energy intake reduction (not a metabolism boost)Saxenda does not significantly increase resting metabolism. It mainly helps you eat less by targeting hunger-driven eating—an important distinction versus common weight-loss myths.
How Saxenda regulates appetite step-by-step
Interactive overview (informational only).
Saxenda dosing & treatment timeline
Saxenda follows a structured dose escalation plan to improve tolerability. The table below matches a typical schedule; your clinician may adjust pacing.
What to expect over time
Weeks 1–2
- Mild appetite suppression may begin.
- Early adjustment to daily injections and possible GI effects.
Weeks 3–5
- Noticeable reduction in hunger for many as dose increases.
- Improved portion control when titration is tolerated.
Months 2–3
- Gradual, more consistent weight change for some users.
- Cravings may feel easier to manage alongside habits.
Months 4+
- Sustained weight reduction for those who continue treatment and lifestyle support.
- More stable eating patterns when daily dosing is maintained.
Weight loss progression over time
Illustrative chart — not a personal forecast.
When does Saxenda start working?
Most users begin to notice appetite changes within the first 1–2 weeks. Clinically meaningful weight loss typically builds over several weeks, especially after reaching the maintenance dose, with consistency important because dosing is daily.
Clinical effectiveness & results
Clinical studies show that liraglutide can support meaningful weight loss when combined with lifestyle changes. In major trials published in journals such as The New England Journal of Medicine, patients using liraglutide achieved roughly around 5–8% average body weight loss over 56 weeks versus placebo in trial populations, with greater results often seen in those who maintained consistent use and support. Individual outcomes vary.
Weekly dose escalation (reference)
Typical escalation reduces nausea risk, helps the body adapt, and supports adherence. Your prescriber may differ from this schedule.
| Week | Dose (daily) |
|---|---|
| Week 1 | 0.6 mg |
| Week 2 | 1.2 mg |
| Week 3 | 1.8 mg |
| Week 4 | 2.4 mg |
| Week 5+ | 3.0 mg (maintenance) |
UK Saxenda pack prices at a glance
Every pack size (1, 3, 5 pens) is visible for our sample pharmacies. On the comparison page you get sort, filters, delivery, trust blocks, and the same styling as here.
| Provider | Reviews | 1 pen | 3 pens | 5 pens |
|---|---|---|---|---|
| Superdrug Online Doctor10% off for Members | 4.6(3,200) | £47£2.61/mg | £135£2.50/mg | £215£2.39/mg |
| Lloyds Pharmacy Online Doctor | 4.4(2,100) | £49£2.72/mg | £135£2.50/mg | £210£2.33/mg |
| Boots Online Doctor | 4.5(5,000) | £51£2.83/mg | £145£2.69/mg | £235£2.61/mg |
Interactive table: sort, filter, and discount preview on the comparison page. Open full comparison table | ||||
Prescription-only — a qualified clinician must assess you before supply. Illustrative figures; confirm live checkout prices.
Saxenda vs newer treatments
Compared with newer weekly GLP-1 (or dual-pathway) medicines, Saxenda requires daily injections, typically produces more moderate average weight loss in trial populations, and has a longer track record of use for some patients—factors that matter for personal preference and clinical choice.
| Saxenda (liraglutide) | Wegovy (semaglutide) | Mounjaro (tirzepatide) | |
|---|---|---|---|
| Dosing | Once daily | Once weekly | Once weekly |
| Mechanism | GLP-1 agonist | GLP-1 agonist | GIP + GLP-1 agonist |
| Trial weight loss (headline) | ~5–8% mean vs placebo at 56 w (SCALE-style) | Higher mean loss in STEP-style 68 w trials | Higher mean loss in SURMOUNT programme trials |
| Considerations | Choice depends on eligibility, side effects, convenience, cost, and prescriber advice—not marketing claims alone. | ||
Side effects & safety profile
Common side effects can include nausea, vomiting, diarrhoea or constipation, headache, and fatigue. They are often linked to slower digestion and hormonal changes in appetite regulation, and may improve as the body adapts.
Management tips: eat smaller meals, avoid very high-fat meals early on, stay hydrated, and increase dose only as prescribed. Seek urgent care for severe or persistent symptoms as described in your patient information.
Who is Saxenda suitable for?
Saxenda may be prescribed for adults with BMI ≥ 30 (obesity) or BMI ≥ 27 with weight-related conditions, subject to exclusions and specialist assessment. NICE TA664 describes use within specialist tier 3 weight-management pathways in the NHS context; private providers apply their own clinical criteria.
It is not suitable for everyone, and a medical consultation is required before starting treatment.
How to get Saxenda in the UK
- NHS — may be available via specialist weight-management services when NICE and local criteria are met.
- Private online clinics & pharmacies — consultation and prescribing if clinically appropriate.
- Private specialists — obesity or endocrine clinics may offer GLP-1 pathways.
Best Saxenda providers (UK orientation)
Illustrative providers in our tables include Boots Online Doctor, Superdrug Online Doctor, and Simple Online Pharmacy. Compare monthly all-in cost, consultation rules, and cold-chain delivery before you choose.
Trust & verification
- Only use UK pharmacies regulated by the GPhC or equivalent for supply.
- Expect a proper consultation before any prescription-only medicine.
- Cold-chain products should ship with appropriate packaging—ask if unsure.
- Cross-check the pharmacy’s GPhC registration number on the official register.
FAQ
What is Saxenda and how is it taken?
Saxenda (liraglutide) is a prescription GLP-1 injection for weight management in eligible adults. Unlike weekly pens such as Wegovy or Mounjaro, Saxenda is injected once daily. Your prescriber increases the dose gradually to improve tolerability.
How much weight can you lose on Saxenda?
In major trials, average weight loss with liraglutide 3 mg plus lifestyle support was often in the region of roughly 5–8% of body weight over about a year compared with placebo—individual results vary widely and depend on adherence, dose, and lifestyle.
Is Saxenda as strong as Mounjaro or Wegovy?
Headline trial averages for newer weekly agents have often been higher than historical liraglutide trials, but the right medicine depends on your health profile, preferences (daily vs weekly), access, cost, and prescriber advice—not headline percentages alone.
Medically reviewed & editorial standards
This guide is written for general education and price transparency. It is reviewed against reputable UK and international sources. It does not replace a consultation with a prescriber who knows your history.
References
- NHS. Saxenda. nhs.uk
- NICE. Liraglutide for managing overweight and obesity (TA664). nice.org.uk
- Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015.
- MHRA. UK medicines regulation & safety updates. gov.uk
